134 related articles for article (PubMed ID: 15148549)
1. Perindopril protects diabetics with coronary disease from cardiovascular death and heart attacks.
Cardiovasc J S Afr; 2004; 15(2):98. PubMed ID: 15148549
[No Abstract] [Full Text] [Related]
2. PERSUADE...(a EUROPA sub-study)...results: perindopril protects diabetic patients with coronary disease from cardiovascular death and heart attacks.
Cardiovasc J S Afr; 2004; 15(3):146. PubMed ID: 15356914
[No Abstract] [Full Text] [Related]
3. The effect of perindopril on cardiovascular morbidity and mortality in patients with diabetes in the EUROPA study: results from the PERSUADE substudy.
Daly CA; Fox KM; Remme WJ; Bertrand ME; Ferrari R; Simoons ML;
Eur Heart J; 2005 Jul; 26(14):1369-78. PubMed ID: 15860521
[TBL] [Abstract][Full Text] [Related]
4. Perindopril in diabetes: perspective from the EUROPA substudy, PERSUADE.
Verma S; Leiter LA; Lonn EM; Strauss MH
Eur Heart J; 2005 Jul; 26(14):1347-9. PubMed ID: 15872030
[No Abstract] [Full Text] [Related]
5. New pathophysiological insights explain life-saving benefits of perindopril in coronary artery disease patients.
Cardiovasc J S Afr; 2004; 15(5):248-9. PubMed ID: 15483736
[No Abstract] [Full Text] [Related]
6. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
[TBL] [Abstract][Full Text] [Related]
7. Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
White HD
Lancet; 2003 Sep; 362(9386):755-7. PubMed ID: 13678865
[No Abstract] [Full Text] [Related]
8. The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.
Brugts JJ; Ninomiya T; Boersma E; Remme WJ; Bertrand M; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML
Eur Heart J; 2009 Jun; 30(11):1385-94. PubMed ID: 19346520
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: a subgroup analysis of the EUROPA trial.
Bertrand ME; Fox KM; Remme WJ; Ferrari R; Simoons ML
Arch Cardiovasc Dis; 2009 Feb; 102(2):89-96. PubMed ID: 19303575
[TBL] [Abstract][Full Text] [Related]
10. [ACE-inhibitor effects on the stabilization of coronary heart disease. EUROPA study].
Böhm M
Internist (Berl); 2004 Oct; 45(10):1196-8. PubMed ID: 15372169
[No Abstract] [Full Text] [Related]
11. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).
Fox KM;
Lancet; 2003 Sep; 362(9386):782-8. PubMed ID: 13678872
[TBL] [Abstract][Full Text] [Related]
12. Perindopril (Coversyl) prevents cardiovascular death and MI in coronary disease patients regardless of their cardiovascular risk.
Opie L; Dalby T; Naidoo DP
Cardiovasc J S Afr; 2003; 14(5):277-9. PubMed ID: 14664228
[No Abstract] [Full Text] [Related]
13. [Coronary heart disease patient with no ischemic symptoms. Does he still profit from an ACE inhibitor?].
MMW Fortschr Med; 2003 Sep; 145(38):12. PubMed ID: 14603673
[No Abstract] [Full Text] [Related]
14. [Preventive therapy with ACE inhibitors for coronary patients].
Keltai M
Orv Hetil; 2004 Feb; 145(9):461-5. PubMed ID: 15077477
[TBL] [Abstract][Full Text] [Related]
15. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
Ferrari R; Ambrosio G; Chiariello M
Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
[No Abstract] [Full Text] [Related]
16. ACE inhibitors: the impact of the EUROPA study on CAD.
Cardiovasc J S Afr; 2003; 14(4):211-2. PubMed ID: 14619870
[No Abstract] [Full Text] [Related]
17. The EUROPA trial.
Brophy JM
Lancet; 2003 Dec; 362(9399):1936; author reply 1936-7. PubMed ID: 14667759
[No Abstract] [Full Text] [Related]
18. Should angiotensin-converting enzyme inhibitors be used in all patients with coronary artery disease or restricted to those with a history of myocardial infarction or myocardial revascularization?
Danchin N
Arch Cardiovasc Dis; 2009 Feb; 102(2):81-3. PubMed ID: 19303573
[No Abstract] [Full Text] [Related]
19. ["Using chance, despite high NNT"].
Zeiher A
MMW Fortschr Med; 2003 Sep; 145(38):12. PubMed ID: 14603674
[No Abstract] [Full Text] [Related]
20. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
Bertrand ME; Remme WJ; Fox KM; Ferrari R; Simoons ML;
Int J Cardiol; 2007 Sep; 121(1):57-61. PubMed ID: 17270296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
